FIELD: medicine. SUBSTANCE: platinum cytostatic containing cis-diamine-1,1-cyclobutanedicarboxylatoplatinum complex of the formula in the form of particles of the following distribution by size: 0-25 mcm - 60%, not less; 0-50 mcm - 95%, not less; 0-75 mcm - 99%, not less; purity is 98%, not less; silver content is 1×10-5%, not above. Complex is prepared by interaction of 1,1-cyclobutanedicarboxylic acid or its salt, or ester with cis-diaminedihalogenplatinum complex at the ratio 1: (1-5) mas. p. at pH 5.9-7.5, in medium with 3-30 mas. p. water containing 1-10 mas. p. organic solvent, at temperature from 20 to 100 C and sonic wave treatment followed by purification. EFFECT: improved method of preparing. 7 cl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR INJECTIONS | 2007 |
|
RU2443432C2 |
PLATINUM COMPLEX COMPOUNDS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2203901C2 |
CARBOPLATIN-BASE PHARMACEUTICAL COMPOSITION SHOWING ANTITUMOR ACTIVITY | 1999 |
|
RU2188640C1 |
METHOD OF OBTAINING CIS-DIAMMINO(1,1-CYCLOBUTANEDICARBOXYLATE)PLATINUM(II) | 2006 |
|
RU2330039C1 |
PHARMACEUTICAL COMPOSITION FOR INJECTION PARTICULARLY TARGETED LOCAL ADMINISTRATION | 2007 |
|
RU2440113C2 |
METHOD OF OBTAINING CIS-DIAMMONIUM-DICHLORODIHYDROXOPLATINUM (IV) AND ITS APPLICATION | 2004 |
|
RU2345086C2 |
PLATINUM (IV) COMPLEXES WITH HIGH ANTITUMOR EFFICIENCY | 2014 |
|
RU2666898C1 |
METHOD OF PRODUCING MODIFIED BISMUTH POWDER | 2010 |
|
RU2424876C1 |
METHOD FOR TUMOUR GROWTH INHIBITION | 2012 |
|
RU2491930C1 |
METHOD OF OBTAINING PLATINUM-DIAMINE COMPLEXES | 0 |
|
SU1160937A3 |
Authors
Dates
1996-02-20—Published
1988-01-12—Filed